Contents:

Wound Treatments in Mexico Euromonitor International June 2010 List of Contents and Tables Executive Summary Dynamic Growth in Consumer Health Comes To A Halt in 2009 H1n1 Influenza Epidemic Transforms Perception of Self-medication Emerging Strength of Generic Products Shapes the Regulatory Environment Retailing Becomes An Important Battle Ground for Pharmaceutical Companies Retail Value To Flatten Over the Forecast Period Key Trends and Developments Mexicans Move To Low-priced Products Generics and Private Label Increase Sales New Legislation To Affect Imports and the Drug Registry Self-care Education Still Lagging Chronic Diseases To Drive Growth the Creativity of OTC Drug Advertising in Mexico Retailing Becomes A Major Scenario for Competitive Wars Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009 Table 2 Life Expectancy at Birth 2004-2009 Market Data Table 3 Sales of Consumer Health by Sector: Value 2004-2009 Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009 Table 5 Consumer Health Company Shares by Value 2005-2009 Table 6 Consumer Health Brand Shares by Value 2006-2009 Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009 Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009 Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014 Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014 Appendix OTC Registration and Classification Vitamins and Dietary Supplements Registration and Classification Self-medication/self-care and Preventative Medicine Switches Summary 1 OTC Healthcare Switches 2007-2009 Definitions Sector and Subsector Definitions Summary 2 Research Sources Bayer De México SA De Cv Strategic Direction Key Facts Summary 3 Bayer de México SA de CV: Key Facts Summary 4 Bayer de México SA de CV: Operational Indicators Company Background Production Summary 5 Bayer de México SA de CV: Production Statistics 2009 Competitive Positioning Summary 6 Bayer de México SA de CV: Competitive Position 2009 Boehringer Ingelheim Promeco SA De Cv Strategic Direction Key Facts Summary 7 Boehringer Ingelheim Promeco SA de CV: Key Facts Summary 8 Boehringer Ingelheim Promeco SA de CV: Operational Indicators Company Background Production Summary 9 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2009 Competitive Positioning Summary 10 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2009 Farmacias Similares SA De Cv Strategic Direction Key Facts Summary 11 Farmacias Similares SA de CV: Key Facts Summary 12 Farmacias Similares SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 13 Farmacias Similares SA de CV: Competitive Position 2009 Genomma Lab Internacional Sab De Cv Strategic Direction Key Facts Summary 14 Genomma Lab Internacional SAB de CV: Key Facts Summary 15 Genomma Lab Internacional SAB de CV: Operational Indicators Company Background Production Competitive Positioning Summary 16 Genomma Lab Internacional SAB de CV: Competitive Position 2009 GlaxoSmithKline México SA De Cv Strategic Direction Key Facts Summary 17 GlaxoSmithKline México SA de CV: Key Facts Summary 18 GlaxoSmithKline México SA de CV: Operational Indicators Company Background Production Summary 19 GlaxoSmithKline México SA de CV: Production Statistics 2009 Competitive Positioning Herbalife Internacional De México SA De Cv Strategic Direction Key Facts Summary 21 Herbalife Internacional de México SA de CV: Key Facts Summary 22 Herbalife Internacional de México SA de CV: Operational Indicators Company Background Production Competitive Positioning Summary 23 Herbalife Internacional de México SA de CV: Competitive Position 2009 Merck-méxico SA Strategic Direction Key Facts Summary 24 Merck-México SA: Key Facts Summary 25 Merck-México SA: Operational Indicators Company Background Production Summary 26 Merck-México SA: Production Statistics 2009 Competitive Positioning Summary 27 Merck-México SA: Competitive Position 2009 Pfizer SA De Cv Strategic Direction Key Facts Summary 28 Pfizer SA de CV: Key Facts Summary 29 Pfizer SA de CV: Operational Indicators Company Background Production Summary 30 Pfizer SA de CV: Production Statistics 2009 Competitive Positioning Summary 31 Pfizer SA de CV: Competitive Position 2009 Summary 32 Wyeth SA de CV: Competitive Position 2009 Trends Category Data Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009 Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009 Table 13 Wound Treatments Company Shares by Value 2005-2009 Table 14 Wound Treatments Brand Shares by Value 2006-2009 Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014 Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014

Companies Mentioned

- Bayer De Mxico SA De Cv - Boehringer Ingelheim Promeco SA De Cv - Farmacias Similares SA De Cv - Genomma Lab Internacional Sab De Cv - GlaxoSmithKline Mxico SA De Cv - Herbalife Internacional De Mxico SA De Cv - Merck-mxico SA - Pfizer SA De Cv